From Medscape Neurology

Coverage from the

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2025

February 27 - March 01, 2025; West Palm Beach, Florida

February 27 - March 01, 2025 West Palm Beach, Florida

Conference News

ACTRIMS 2025 Is MS Subtyping Clinically Meaningful? Experts Weigh In
Medscape Medical News, March 14, 2025
ACTRIMS 2025 Proposed Multiple Sclerosis Criteria Boost Diagnostic Yield
Medscape Medical News, March 7, 2025
ACTRIMS 2025 New Support for Ketogenic Diet in Multiple Sclerosis
Medscape Medical News, March 6, 2025

ACTRIMS 2025 More Evidence PRLs a Potential Therapeutic Target in MS
Medscape Medical News, March 6, 2025
ACTRIMS 2025 Paramagnetic Rim Lesions May Aid MS Diagnosis and Treatment
Medscape Medical News, March 3, 2025
ACTRIMS 2025 Stopping DMTs in Older MS Patients: What the Data Show
Medscape Medical News, March 3, 2025

Medscape Neurology©

Perspectives

Disease-Modifying Therapies for RRMS From ACTRIMS 2025
Pavan Bhargava, MD

Popular News From ACTRIMS 2024

Migraine a Forerunner of Multiple Sclerosis? A common comorbidity in multiple sclerosis migraine is not part of the 3- to 5-year disease prodrome, new research suggested.
Medscape Medical News, Mar 06, 2024
'No Surprises' as Ozanimod Holds up in RMS Extension Trial Nearly 70% of patients with relapsing forms of MS were relapse-free at 5 years, but hematologists disagree over where the drug fits in the treatment plan.
Medscape Medical News, Mar 05, 2024
An Easy, Effective Solution to Heat Sensitivity in RRMS? Aspirin and acetaminophen may offer an effective and inexpensive solution to exercise-induced heat sensitivity in relapsing-remitting multiple sclerosis, phase 3 data suggested.
Medscape Medical News, Mar 14, 2024

Previous Coverage

Related Resources

Multiple Sclerosis

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.